These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29966684)

  • 1. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives.
    Kotla NG; Rana S; Sivaraman G; Sunnapu O; Vemula PK; Pandit A; Rochev Y
    Adv Drug Deliv Rev; 2019 Jun; 146():248-266. PubMed ID: 29966684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
    Dos Santos AM; Carvalho SG; Meneguin AB; Sábio RM; Gremião MPD; Chorilli M
    J Control Release; 2021 Jun; 334():353-366. PubMed ID: 33901582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharides: a targeting strategy for colonic drug delivery.
    Shah N; Shah T; Amin A
    Expert Opin Drug Deliv; 2011 Jun; 8(6):779-96. PubMed ID: 21506904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosa.
    Sharma S; Sinha VR
    J Control Release; 2018 Feb; 272():97-106. PubMed ID: 29317245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa.
    Dar MJ; Ali H; Khan A; Khan GM
    J Drug Target; 2017 Aug; 25(7):582-596. PubMed ID: 28277824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease.
    Zhang Y; Thanou M; Vllasaliu D
    Eur J Pharm Biopharm; 2020 Oct; 155():128-138. PubMed ID: 32853696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances.
    Hu S; Zhao R; Xu Y; Gu Z; Zhu B; Hu J
    J Mater Chem B; 2023 Dec; 12(1):13-38. PubMed ID: 38018424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges.
    Nunes R; Neves JD; Sarmento B
    Nanomedicine (Lond); 2019 Oct; 14(19):2631-2644. PubMed ID: 31612773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.
    Zhang S; Ermann J; Succi MD; Zhou A; Hamilton MJ; Cao B; Korzenik JR; Glickman JN; Vemula PK; Glimcher LH; Traverso G; Langer R; Karp JM
    Sci Transl Med; 2015 Aug; 7(300):300ra128. PubMed ID: 26268315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.
    Boal Carvalho P; Cotter J
    Drugs; 2017 Feb; 77(2):159-173. PubMed ID: 28078646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice.
    Sudirman S; Hsu YH; He JL; Kong ZL
    PLoS One; 2018; 13(10):e0205252. PubMed ID: 30289911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
    Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
    J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery.
    Zhang L; Sang Y; Feng J; Li Z; Zhao A
    J Drug Target; 2016 Aug; 24(7):579-89. PubMed ID: 26766303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis.
    Gheorghe C; Cotruta B; Iacob R; Becheanu G; Dumbrava M; Gheorghe L
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):423-6. PubMed ID: 22187709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
    Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.